These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 6278481)

  • 1. Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture.
    Rotsztejn WH; Dussaillant M; Nobou F; Rosselin G
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7584-8. PubMed ID: 6278481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)].
    Rotsztejn W; Benoist L; Besson J; Duval J
    C R Seances Acad Sci D; 1980 Mar; 290(12):791-3. PubMed ID: 6769606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin 1 (lipocortin 1) mediates the glucocorticoid inhibition of cyclic adenosine 3',5'-monophosphate-stimulated prolactin secretion.
    Taylor AD; Philip JG; John CD; Cover PO; Morris JF; Flower RJ; Buckingham JC
    Endocrinology; 2000 Jun; 141(6):2209-19. PubMed ID: 10830310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release.
    Rotsztejn WH; Benoist L; Besson J; Beraud G; Bluet-Pajot MT; Kordon C; Rosselin G; Duval J
    Neuroendocrinology; 1980 Oct; 31(4):282-6. PubMed ID: 7422069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells.
    Rodríguez de Fonseca F; Wenger T; Navarro M; Murphy LL
    Brain Res; 1999 Sep; 841(1-2):114-22. PubMed ID: 10546994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depolarization counteracts glucocorticoid inhibition of adenohypophysical corticotroph cells.
    Lim MC; Shipston MJ; Antoni FA
    Br J Pharmacol; 1998 Aug; 124(8):1735-43. PubMed ID: 9756391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin 1 dependent and independent mechanisms.
    Taylor AD; Cowell AM; Flower RJ; Buckingham JC
    Neuroendocrinology; 1995 Nov; 62(5):530-42. PubMed ID: 8559285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release.
    Gourdji D; Bataille D; Vauclin N; Grouselle D; Rosselin G; Tixier-Vidal A
    FEBS Lett; 1979 Aug; 104(1):165-8. PubMed ID: 89971
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid inhibition by somatostatin of vasoactive intestinal peptide-induced prolactin secretion by rat pituitary cells. Relationship to cyclic AMP accumulation.
    Rostene WH; Dussaillant M; Rosselin G
    FEBS Lett; 1982 Sep; 146(1):213-6. PubMed ID: 6183146
    [No Abstract]   [Full Text] [Related]  

  • 12. A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release.
    Pizzi M; Memo M; Benarese M; Simonazzi E; Missale C; Spano PF
    Neuroendocrinology; 1990 Apr; 51(4):481-6. PubMed ID: 2161088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of VIP on prolactinemia in turkey anterior pituitary cells: role of cAMP second messenger in VIP-induced prolactin gene expression.
    Kang SW; Youngren OM; El Halawani ME
    Regul Pept; 2002 Nov; 109(1-3):39-44. PubMed ID: 12409212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone inhibits the release of TSH from the rat anterior pituitary gland in vitro by mechanisms dependent on de novo protein synthesis and lipocortin 1.
    Taylor AD; Flower RJ; Buckingham JC
    J Endocrinol; 1995 Dec; 147(3):533-44. PubMed ID: 8543924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription of the vasoactive intestinal peptide gene in response to glucocorticoids: differential regulation of alternative transcripts is modulated by a labile protein in rat anterior pituitary.
    Chew LJ; Burke ZD; Morgan H; Gozes I; Murphy D; Carter DA
    Mol Cell Endocrinol; 1997 Jun; 130(1-2):83-91. PubMed ID: 9220024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
    Bjøro T; Ostberg BC; Sand O; Gordeladze J; Iversen JG; Torjesen PA; Gautvik KM; Haug E
    Mol Cell Endocrinol; 1987 Feb; 49(2-3):119-28. PubMed ID: 2435588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments.
    Pizzi M; Arrighi V; Galli P; Memo M; Spano PF
    Eur J Endocrinol; 1994 Apr; 130(4):361-5. PubMed ID: 8162165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary.
    Lam KS; Srivastava G; Tam SP
    Neuroendocrinology; 1992 Jul; 56(1):32-7. PubMed ID: 1641071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion.
    Onali P; Eva C; Olianas MC; Schwartz JP; Costa E
    Mol Pharmacol; 1983 Sep; 24(2):189-94. PubMed ID: 6310360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.